Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften Toetsvragen Web-tv Video Audio
Tips voor Mijn BSL
Inloggen
Top
Quality of Life Research
Gepubliceerd in:

05-09-2015 | Brief Communication

Psychometric analysis of the Korean version of the high-dose chemotherapy specific quality of life questionnaire module from the European Organization for Research and Treatment of Cancer (EORTC QLQ-HDC29)

Auteurs: Kyung Im Kim, Jae Hyun Kim, Eun Hee Ji, Jun Ho Jang, Jin Seok Kim, Ji-Hyun Kwon, Inho Kim, Seonyang Park, Galina Velikova, Sung-Soo Yoon, Jung Mi Oh

Gepubliceerd in: Quality of Life Research | Uitgave 4/2016

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Purpose

We evaluated the psychometric properties of the Korean version of the European Organization for Research and Treatment of Cancer high-dose chemotherapy specific quality of life questionnaire module (EORTC QLQ-HDC29) when implemented with Korean patients by conducting a multicenter, longitudinal study in three Korean hospitals.

Methods

A total of 226 patients who scheduled to receive the HDC followed by hematopoietic stem cell transplantation (HSCT) were enrolled. The patients were asked to complete three questionnaires [the EORTC Core Questionnaire (QLQ-C30), QLQ-HDC29, and the Functional Assessment of Cancer Therapy-Bone Marrow Transplantation] at four points in time: before HSCT and 100, 180, and 365 days after HSCT. Standard validity and reliability analyses were performed.

Results

Internal consistency of the QLQ-HDC29 was generally acceptable, as tested by Cronbach’s α, except for the scales body image and the inpatient issues. Cronbach’s α values for the Korean version of the QLQ-HDC29 were almost in accordance with results of the original version, except for the scales body image (lower to the original QLQ-HDC29, α = 0.73) and impact on family (higher to the original QLQ-HDC29, α = 0.52). Known-group comparison analyses showed significantly higher symptom burdens in patients with poor performance status or graft versus host disease (similar to the original QLQ-HDC29). The QLQ-HDC29 indicated good convergent and discriminant validity and showed responsiveness to changes in line with a clinical course over time after HSCT.

Conclusions

The QLQ-HDC29 is generally reliable and adequate to assess QoL in Korean patients undergoing HDC followed by HSCT.
vorige artikel Assessment of the psychometric properties of the Chinese Impact of Vision Impairment questionnaire in a population-based study: findings from the Singapore Chinese Eye Study
volgende artikel Mapping the EORTC QLQ-C30 onto the EQ-5D-3L: assessing the external validity of existing mapping algorithms
Literatuur
1.
Gratwohl, M., Aljurf, M., Bouzas, L. F., Horowitz, M., Kodera, Y., Lipton, J., et al. (2013). Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: A Global Observational Study. Haematologica, 98(8), 1282–1290.CrossRefPubMedPubMedCentral
2.
Gooley, T. A., Chien, J. W., Pergam, S. A., Hingorani, S., Sorror, M. L., Boeckh, M., et al. (2010). Reduced mortality after allogeneic hematopoietic-cell transplantation. New England Journal of Medicine, 363(22), 2091–2101.CrossRefPubMedPubMedCentral
3.
Neitzert, C. S., Ritvo, P., Dancey, J., Weiser, K., Murray, C., & Avery, J. (1998). The psychosocial impact of bone marrow transplantation: A review of the literature. Bone Marrow Transplantation, 22(5), 409–422.CrossRefPubMed
4.
McQuellon, R. P., Russell, G. B., Cella, D. F., Craven, B. L., Brady, M., Bonomi, A., & Hurd, D. D. (1997). Quality of life measurement in bone marrow transplantation: Development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale. Bone Marrow Transplantation, 19(4), 357–368.CrossRefPubMed
5.
Velikova, G., Weis, J., Hjermstad, M. J., Kopp, M., Morris, P., Watson, M., et al. (2007). The EORTC QLQ-HDC29: A supplementary module assessing the quality of life during and after high-dose chemotherapy and stem cell transplantation. European Journal of Cancer, 43(1), 87–94.CrossRefPubMed
6.
Dewolf, L., Koller, M., Velikova, G., Johnson, C., Scott, N., & Bottomley, A. (2009). EORTC quality of life group translation procedure (3rd ed.). Brussels: European Organisation for Research and Treatment of Cancer.
7.
Tabachnik, B. J., & Fidel, L. S. (1993). Using multivariate statistics. London: Harper & Row.
8.
Zubord, C., Scheiderman, M., & Frei, E. (1960). Appraisal of methods for the study of chemotherapy in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. Journal of Chronic Diseases, 11, 7–33.CrossRef
9.
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365–376.CrossRefPubMed
10.
Yun, Y. H., Park, Y. S., Lee, E. S., Bang, S. M., Heo, D. S., Park, S. Y., et al. (2004). Validation of the Korean version of the EORTC QLQ-C30. Quality of Life Research, 13(4), 863–868.CrossRefPubMed
11.
Yoo, H., Lee, K., Lee, J., Eremenco, S., Choi, S., Kim, H., & Lee, J. (2006). Korean translation and validity of FACT-BMT version 4 and the quality of life in allogeneic bone marrow transplantation patients. Quality of Life Research, 15(3), 559–564.CrossRefPubMed
12.
Ware, J. E., Harris, W. J., Gandek, B., Rogers, B. W., & Reese, P. R. (1997). MAP-R for Windows: Multitrait/multi-item analysis program—Revised user’s guide. Boston: Health Assessment Lab.
13.
Cronbach, L. J. (1951). Coefficient alpha and the internal structure of tests. Psychometrika, 16, 297.CrossRef
14.
George, D., & Mallery, P. (2003). SPSS for Windows step by step: A simple guide and reference. 11.0 update (4th ed.). Boston: Allyn & Bacon.
15.
Kline, P. (2000). The handbook of psychological testing (2nd ed.). London: Routledge.
16.
Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale: Lawrence Erlbaum Associates.
17.
Lee, Y., Lim, M. C., Son, Y., Joo, J., Park, K., Kim, J. S., et al. (2014). Development and evaluation of Korean version of Quality of Sexual Function (QSF-K) in healthy Korean women. Journal of Korean Medical Science, 29(6), 758–763.CrossRefPubMedPubMedCentral
18.
Pallua, S., Giesinger, J., Oberguggenberger, A., Kemmler, G., Nachbaur, D., Clausen, J., et al. (2010). Impact of GvHD on quality of life in long-term survivors of haematopoietic transplantation. Bone Marrow Transplantation, 45(10), 1534–1539.CrossRefPubMed
19.
Braamse, A. M., Gerrits, M. M., van Meijel, B., Visser, O., van Oppen, P., Boenink, A. D., et al. (2012). Predictors of health-related quality of life in patients treated with auto- and allo-SCT for hematological malignancies. Bone Marrow Transplantation, 47(6), 757–769.CrossRefPubMed
20.
Baker, K. S., & Fraser, C. J. (2008). Quality of life and recovery after graft-versus-host disease. Best Practice & Research Clinical Haematology, 21(2), 333–341.CrossRef
21.
Kiss, T. L., Abdolell, M., Jamal, N., Minden, M. D., Lipton, J. H., & Messner, H. A. (2002). Long-term medical outcomes and quality-of-life assessment of patients with chronic myeloid leukemia followed at least 10 years after allogeneic bone marrow transplantation. Journal of Clinical Oncology, 20(9), 2334–2343.CrossRefPubMed
22.
Cella, D. (1997). Manual of the Functional Assessment of Chronic Illness Therapy (FACIT) measurement system. Evanston, IL: Center on Outcomes, Research and Education (CORE), Evanston Northwestern Healthcare and Northwestern University.
23.
Syrjala, K. L., Langer, S. L., Abrams, J. R., Storer, B., Sanders, J. E., Flowers, M. E., & Martin, P. J. (2004). Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma. Journal of the American Medical Association, 291(19), 2335–2343.CrossRefPubMed
24.
Bevans, M. F., Marden, S., Leidy, N. K., Soeken, K., Cusack, G., Rivera, P., et al. (2006). Health-related quality of life in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation, 38(2), 101–109.CrossRefPubMed
25.
Wong, F. L., Francisco, L., Togawa, K., Bosworth, A., Gonzales, M., Hanby, C., et al. (2010). Long-term recovery after hematopoietic cell transplantation: Predictors of quality-of-life concerns. Blood, 115(12), 2508–2519.CrossRefPubMedPubMedCentral
Metagegevens
Titel
Psychometric analysis of the Korean version of the high-dose chemotherapy specific quality of life questionnaire module from the European Organization for Research and Treatment of Cancer (EORTC QLQ-HDC29)
Auteurs
Kyung Im Kim
Jae Hyun Kim
Eun Hee Ji
Jun Ho Jang
Jin Seok Kim
Ji-Hyun Kwon
Inho Kim
Seonyang Park
Galina Velikova
Sung-Soo Yoon
Jung Mi Oh
Publicatiedatum
05-09-2015
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 4/2016
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-015-1121-5

Andere artikelen Uitgave 4/2016

Insurance status and health-related quality-of-life disparities after trauma: results from a nationally representative survey in the US

Comparison of interactive voice response (IVR) with paper administration of instruments to assess functional status, sexual function, and quality of life in elderly men

Erratum to: Distilling the essence of appraisal: a mixed methods study of people with multiple sclerosis

  • Erratum

The quality of systematic reviews of health-related outcome measurement instruments

  • Open Access
  • Review

Association between nutritional status and subjective health status in chronically ill children attending special schools

  • Open Access

Is bad living better than good death? Impact of demographic and cultural factors on health state preference